FDA MedWatch News FDA Warnings
 
Ennis & Ennis, P.A. is a national law firm that specializes in mass torts, defective medical devices and product liability cases. If you have been injured you need to know your legal rights. Contact the lawyers of Ennis & Ennis today for a free case evaluation.
Ennis & Ennis, P.A. News
Free Case Evaluation

FDA MedWatch

Rituxan (rituximab) - PML

Audience: Rheumatological healthcare professionals

10/23/2009 - Genentech and FDA notified healthcare professionals about a third case of progressive multifocal leukoencephalopathy [PML], the first case of PML in a patient with rheumatoid arthritis [RA] treated with Rituxan who has not previously received treatment with a TNF antagonist. Information to date suggests that patients with RA who receive Rituxan have an increased risk of PML.

Physicians should consider PML in any patient being treated with Rituxan who presents with new onset neurologic manifestations. Consultation with a neurologist, brain MRI, and lumbar puncture should be considered as clinically indicated.

Read the complete MedWatch 2009 Safety summary, including a link to the Dear Healthcare Professional letter and prescribing information, at:

http://www.fda.gov/Safety/MedWatch/SafetyInformation/
SafetyAlertsforHumanMedicalProducts/ucm187791.htm

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 
Required fields in yellow
 
Name:
Email:
 
Telephone: (123-123-1234)
 
Mailing Address:
 
City:
 
State:
 
Zip Code:
Please List Defective Product You Are Inquiring About:
Please List Any Side Effects, Injuries, or Property Damage:
Additional Information:
 
 

 

 
Nationwide Free Case Evaluations: 1-800-856-6405